NasdaqGM:TRHC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the field of medication safety in the United States.


Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

Share Price & News

How has Tabula Rasa HealthCare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: TRHC's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

8.2%

TRHC

1.1%

US Healthcare Services

3.8%

US Market


1 Year Return

31.8%

TRHC

24.2%

US Healthcare Services

9.7%

US Market

Return vs Industry: TRHC exceeded the US Healthcare Services industry which returned 24.2% over the past year.

Return vs Market: TRHC exceeded the US Market which returned 9.7% over the past year.


Shareholder returns

TRHCIndustryMarket
7 Day8.2%1.1%3.8%
30 Day-6.9%8.6%11.4%
90 Day11.2%19.2%6.8%
1 Year31.8%31.8%24.8%24.2%12.1%9.7%
3 Year303.1%303.1%74.2%73.1%36.2%27.2%
5 Yearn/a67.9%66.3%63.7%45.4%

Price Volatility Vs. Market

How volatile is Tabula Rasa HealthCare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Tabula Rasa HealthCare undervalued compared to its fair value and its price relative to the market?

37.3%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: TRHC ($57.8) is trading below our estimate of fair value ($92.12)

Significantly Below Fair Value: TRHC is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: TRHC is unprofitable, so we can't compare its PE Ratio to the Healthcare Services industry average.

PE vs Market: TRHC is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TRHC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TRHC is overvalued based on its PB Ratio (6.9x) compared to the US Healthcare Services industry average (4.3x).


Next Steps

Future Growth

How is Tabula Rasa HealthCare forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?

41.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TRHC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TRHC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TRHC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TRHC's revenue (16.5% per year) is forecast to grow faster than the US market (8.7% per year).

High Growth Revenue: TRHC's revenue (16.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TRHC's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Tabula Rasa HealthCare performed over the past 5 years?

-35.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TRHC is currently unprofitable.

Growing Profit Margin: TRHC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: TRHC is unprofitable, and losses have increased over the past 5 years at a rate of -35.8% per year.

Accelerating Growth: Unable to compare TRHC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TRHC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (19.1%).


Return on Equity

High ROE: TRHC has a negative Return on Equity (-20.01%), as it is currently unprofitable.


Next Steps

Financial Health

How is Tabula Rasa HealthCare's financial position?


Financial Position Analysis

Short Term Liabilities: TRHC's short term assets ($93.7M) exceed its short term liabilities ($40.3M).

Long Term Liabilities: TRHC's short term assets ($93.7M) do not cover its long term liabilities ($268.1M).


Debt to Equity History and Analysis

Debt Level: TRHC's debt to equity ratio (127.9%) is considered high.

Reducing Debt: TRHC's debt to equity ratio has reduced from 2090.9% to 127.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TRHC has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if TRHC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Tabula Rasa HealthCare's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate TRHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate TRHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if TRHC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TRHC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TRHC's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.7yrs

Average management tenure


CEO

Calvin Knowlton (69yo)

6yrs

Tenure

US$5,135,730

Compensation

Dr. Calvin H. Knowlton, BSc Pharm, MDiv, Ph.D., is a Co-Founder of Tabula Rasa Healthcare, Inc. and has been its Chairman and Chief Executive Officer since June 2014. Dr. Knowlton founded CareKinesis, Inc. ...


CEO Compensation Analysis

Compensation vs Market: Calvin's total compensation ($USD5.14M) is about average for companies of similar size in the US market ($USD4.76M).

Compensation vs Earnings: Calvin's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Calvin Knowlton
Co-Founder6yrsUS$5.14m3.78% $47.4m
Orsula Knowlton
Co-Founder6.42yrsUS$3.81m3.42% $42.9m
Brian Adams
CFO & Secretary6yrsUS$2.63m1.01% $12.6m
Michael Greenhalgh
Chief Operating Officer6yrsno data0.66% $8.3m
Andrea Speers
Corporate Controller & Chief Accounting Officer2.33yrsno data0.19% $2.4m
Thomas Wilson
Chief Technology Innovation Officer & EVP of eHealth Services1.42yrsno datano data
Joseph Filippoli
Chief Information Officer6yrsno datano data
Jacques Turgeon
Chief Scientific Officer4.75yrsno datano data
Phillip Heath
Chief Administrative Officer5.33yrsno datano data
Frank Sparacino
Senior Vice President of Investor Relations & Corporate Development0.25yrno datano data

5.7yrs

Average Tenure

53yo

Average Age

Experienced Management: TRHC's management team is seasoned and experienced (5.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Calvin Knowlton
Co-Founder6yrsUS$5.14m3.78% $47.4m
Orsula Knowlton
Co-Founder6.42yrsUS$3.81m3.42% $42.9m
A. Tunstall
Lead Independent Directorno dataUS$541.50k0.055% $692.9k
Jan Berger
Independent Director1.92yrsUS$217.25k0.050% $623.4k
Dennis Helling
Independent Director3.25yrsUS$223.63k0.059% $742.6k
Michael Purcell
Independent Director1.92yrsUS$234.13k0.050% $623.4k
Samira Beckwith
Independent Director2.83yrsUS$229.25k0.037% $465.3k
Kathrine O'Brien
Independent Director1.58yrsUS$216.00k0.049% $610.7k
Pamela Schweitzer
Independent Director1.25yrsUS$556.00k0.044% $553.5k

2.4yrs

Average Tenure

62yo

Average Age

Experienced Board: TRHC's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.1%.


Top Shareholders

Company Information

Tabula Rasa HealthCare, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Tabula Rasa HealthCare, Inc.
  • Ticker: TRHC
  • Exchange: NasdaqGM
  • Founded: 2009
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$1.255b
  • Shares outstanding: 21.71m
  • Website: https://www.tabularasahealthcare.com

Number of Employees


Location

  • Tabula Rasa HealthCare, Inc.
  • 228 Strawbridge Drive
  • Suite 100
  • Moorestown
  • New Jersey
  • 8057
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TRHCNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDSep 2016
43TDB (Deutsche Boerse AG)YesCommon StockDEEURSep 2016

Biography

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the field of medication safety in the United States. The company’s proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. The company’s cloud-based software applications also comprise RxCompanion, a medication therapy management software platform for the identification and resolution of medication and other health related problems; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) programs; and PACElogic, which deliver real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting for PACE organizations and small health plans. Tabula Rasa HealthCare, Inc. also offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2018, it served 224 healthcare organizations. The company offers its cloud-based software solutions to prescribers, pharmacists, and healthcare organizations for managing the medication-related needs of their patients. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/06/06 06:00
End of Day Share Price2020/06/05 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.